Fungal contribution in chondroradionecrosis of the larynx.
To assess the prevalence of invasive fungal elements in the specimens of patients who underwent salvage total laryngectomy for chondroradionecrosis (CRN) in the absence of recurrent or persistent malignancy.



Retrospective chart review.



Tertiary academic medical center.



One hundred fifty-nine patients were identified who underwent salvage total laryngectomy. Pathology reports were reviewed, and all laryngectomy specimens that did not contain residual malignancy were reevaluated for evidence of invasive fungal elements.



Twelve of 159 (7.5%) patients who underwent total laryngectomy after primary radiotherapy or chemoradiotherapy had no evidence of residual malignancy. Each of these specimens contained histopathologic evidence of CRN; invasive fungal elements were identified in 25%. There was no statistical difference in demographic or treatment-related variables between patients who underwent salvage total laryngectomy with evidence of persistent or recurrent malignancy in the laryngectomy specimen versus patients without evidence of tumor on final histopathologic analysis. Patients with evidence of ulceration or necrosis in the laryngectomy specimen had reduced overall survival, irrespective of the presence of persistent malignancy (hazard ratio = 2.923, 95% confidence interval = 1.023-8.352, P = .045).



Among salvage total laryngectomy patients, no difference was identified between patients who underwent total laryngectomy for recurrent or persistent malignancy after primary radiotherapy and those who received total laryngectomy without evidence of malignancy in their specimens. Invasive fungal elements were detected in several laryngectomy specimens that did not contain residual malignancy. Empiric antifungal therapy may therefore benefit patients diagnosed with CRN who are at risk for progression to nonfunctional larynx. Patients with evidence of ulceration or necrosis in the salvage laryngectomy specimen had worse overall survival.



4. Laryngoscope, 127:E159-E165, 2017.
Department of Otolaryngology-HNS and Communicative Disorders, Louisville, Kentucky, U.S.A.
Mary
M
Worthen
University of Louisville School of Medicine, Louisville, Kentucky, U.S.A.
Mia
M
Jusufbegovic
Department of Otolaryngology-HNS and Communicative Disorders, Louisville, Kentucky, U.S.A.
Jeffrey M
JM
Bumpous
University of Louisville School of Medicine, Louisville, Kentucky, U.S.A.
Andrew
A
Vaughn
Department of Otolaryngology-HNS and Communicative Disorders, Louisville, Kentucky, U.S.A.|Department of Psychological and Brain Sciences, University of Louisville, Louisville, Kentucky, U.S.A.|James Graham Brown Cancer Center, Louisville, Kentucky, U.S.A.
Elizabeth
E
Cash
Department of Pathology, University of Louisville School of Medicine, Louisville, Kentucky, U.S.A.
Xiu
X
Yang
University of Louisville School of Medicine, Louisville, Kentucky, U.S.A.
Craig
C
Fichandler
Department of Otolaryngology-HNS and Communicative Disorders, Louisville, Kentucky, U.S.A.
Paul
P
Tennant
D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy*; D007825:Laryngectomy; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000150:complications* / Q000382:microbiology*; D011832:Radiation Injuries / Q000382:microbiology* / Q000601:surgery*; D012189:Retrospective Studies; D016879:Salvage Therapy; D015996:Survival Rate; D016896:Treatment Outcome
Chondroradionecrosis; fungal invasion; laryngectomy